Controlling the biological function of calcium phosphate bone substitutes with drugs

Acta Biomaterialia

Volumn 8, Issue 10, 2012, Pages 3541-3551

  Verron, E ^a   Bouler, J M ^a   Guicheux, J ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Biological applications; Bone tissue; CaP biomaterials; Drug delivery; Resorption

Indexed keywords

BIOMATERIALS; BONE; CONTROLLED DRUG DELIVERY; DISEASES; TARGETED DRUG DELIVERY; TISSUE ENGINEERING; TUMORS;

BIOLOGICAL APPLICATIONS; BIOLOGICAL FUNCTIONS; BONE REPAIR; BONE SUBSTITUTES; BONE TARGETING; BONE TISSUE; BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE BIOMATERIAL; RESORPTION; TARGETING DRUG DELIVERIES;

CALCIUM PHOSPHATE;

ANALGESIC AGENT; ANTIBIOTIC AGENT; APATITE; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; GALLIUM; GROWTH FACTOR; PHOSPHATE; SOMATOMEDIN; STRONTIUM; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

BONE CELL; BONE PROSTHESIS; BONE REGENERATION; CERAMICS; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; INFECTION; IRRADIATION; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 84865469020     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.06.022     Document Type: Review

References (157)

1. S. Rush Bone graft substitutes: osteobiologics Clin Podiatr Med Surg 22 2005 619 630
2. E. Verron, I. Khairoun, J. Guicheux, and J.M. Bouler Calcium phosphate biomaterials as bone drug delivery systems: a review Drug Discov Today 15 2010 547 552
3. V. Rabenda, R. Mertens, V. Fabri, J. Vanoverloop, F. Sumkay, and C. Vannecke Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women Osteoporos Int 19 2008 811 818
4. R.Z. LeGeros Calcium phosphate materials in restorative dentistry: a review Adv Dent Res 2 1988 164 180
5. S. Tomita, A. Kin, M. Yazu, and M. Abe Biomechanical evaluation of kyphoplasty and vertebroplasty with calcium phosphate cement in a simulated osteoporotic compression fracture J Orthop Sci 8 2003 192 197
6. E.M. Ooms, J.G. Wolke, J.P. van der Waerden, and J.A. Jansen Use of injectable calcium-phosphate cement for the fixation of titanium implants: an experimental study in goats J Biomed Mater Res B: Appl Biomater 66 2003 447 456
7. E.M. Ooms, J.G. Wolke, M.T. van de Heuvel, B. Jeschke, and J.A. Jansen Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone Biomaterials 24 2003 989 1000
8. R.D. Welch, H. Zhang, and D.G. Bronson Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft J Bone Joint Surg Am 85-A 2003 222 231
9. M. Libicher, J. Hillmeier, U. Liegibel, U. Sommer, W. Pyerin, and M. Vetter Osseous integration of calcium phosphate in osteoporotic vertebral fractures after kyphoplasty: initial results from a clinical and experimental pilot study Osteoporos Int 17 2006 1208 1215
10. LeGeros RZ. Calcium phosphate in oral biology and medicine. Monographs in oral sciences, vol. 15; 1991.
11. R.Z. LeGeros Biodegradation and bioresorption of calcium phosphate ceramics Clin Mater 14 1983 65 88
12. O. Gauthier, J.M. Bouler, E. Aguado, P. Pilet, and G. Daculsi Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth Biomaterials 19 1998 133 139
13. A. Le Ray, H. Gautier, J.M. Bouler, P. Weiss, and C. Merle A new technological procedure using sucrose as porogen compound to manufacture porous biphasic calcium phosphate ceramics of appropriate micro- and macrostructure Ceram Int 36 2010 93 101
14. R.Z. LeGeros, J.R. Parsons, G. Daculsi, F. Driessens, D. Lee, and S.T. Liu Significance of the porosity and physical chemistry of calcium phosphate ceramics. Biodegradation-bioresorption Ann NY Acad Sci 523 1988 268 271
15. J.M. Bouler, M. Trecant, J. Delecrin, J. Royer, N. Passuti, and G. Daculsi Macroporous biphasic calcium phosphate ceramics: influence of five synthesis parameters on compressive strength J Biomed Mater Res 32 1996 603 609
16. R.Z. LeGeros, A. Chohayeb, and A. Shulman Apatitic calcium phosphates: possible dental restorative materials J Dent Res 61 1982 343
17. W.E. Brown, and L.C. Chow Effects of neutral salts in a bench-scale caries model J Dent Res 65 1986 1115 1120
18. M.P. Ginebra, T. Traykova, and J.A. Planell Calcium phosphate cements as bone drug delivery systems: a review J Control Release 113 2006 102 110
19. M.P. Ginebra, M. Espanol, E.B. Montufar, R.A. Perez, and G. Mestres New processing approaches in calcium phosphate cements and their applications in regenerative medicine Acta Biomater 6 2010 2863 2873
20. W.C. Chen, J.H. Lin, and C.P. Ju Transmission electron microscopic study on setting mechanism of tetracalcium phosphate/dicalcium phosphate anhydrous-based calcium phosphate cement J Biomed Mater Res A 64 2003 664 671
21. E.B. Montufar, T. Traykova, E. Schacht, L. Ambrosio, M. Santin, and J.A. Planell Self-hardening calcium deficient hydroxyapatite/gelatine foams for bone regeneration J Mater Sci Mater Med 21 2010 863 869
22. M. Julien, I. Khairoun, R.Z. LeGeros, S. Delplace, P. Pilet, and P. Weiss Physico-chemical-mechanical and in vitro biological properties of calcium phosphate cements with doped amorphous calcium phosphates Biomaterials 28 2007 956 965
23. H.H. Xu, and J.B. Quinn Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity Biomaterials 23 2002 193 202
24. J. Zhang, F. Tancret, and J.M. Bouler Fabrication and mechanical properties of calcium phosphate cements (CPC) for bone substitution Mater Sci Eng C 31 2011 740 747
25. Klijn RJ, van den Beucken JJ, Felix Lanao RP, Veldhuis G, Leeuwenburgh SC, Wolke JG, et al. Three different strategies to obtain porous calcium phosphate cements: comparison of performance in a rat skull bone augmentation model. Tissue Eng Part A 2012.
26. Ginebra MP, Canal C, Espanol M, Pastorino D, Montufar EB. Calcium phosphate cements as drug delivery materials. Adv Drug Deliv Rev 2012.
27. M. Espanol, R.A. Perez, E.B. Montufar, C. Marichal, A. Sacco, and M.P. Ginebra Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications Acta Biomater 5 2009 2752 2762
28. E. Verron, and J.M. Bouler Calcium phosphate ceramics as bone drug-combined devices Key Eng Mater: Adv Bioceram Nanomed Tissue Eng 441 2010 181 201
29. E. Verron, O. Gauthier, P. Janvier, H. Le Guen, D. Holopherne, and R. Cavagna Analgesic properties of calcium phosphate apatite loaded with bupivacaine on postoperative pain J Biomed Mater Res B: Appl Biomater 94 2010 89 96
30. M. Itokazu, T. Sugiyama, T. Ohno, E. Wada, and Y. Katagiri Development of porous apatite ceramic for local delivery of chemotherapeutic agents J Biomed Mater Res 39 1998 536 538
31. H. Gautier, C. Merle, J.L. Auget, and G. Daculsi Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method Biomaterials 21 2000 243 249
32. H. Gautier, G. Daculsi, and C. Merle Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and microbiological activity Biomaterials 22 2001 2481 2487
33. T. Namikawa, H. Terai, E. Suzuki, M. Hoshino, H. Toyoda, and H. Nakamura Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model Spine 30 2005 1717 1722
34. E. Wernike, M.O. Montjovent, Y. Liu, D. Wismeijer, E.B. Hunziker, and K.A. Siebenrock VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo Eur Cell Mater 19 2010 30 40
35. L. Wang, H. Shi, Y. Chen, J. Xue, Y. Chen, and Y. Liao Healing of acute alveolar bone dehiscence following treatment with porous biphasic calcium phosphate in beagle dogs Clin Oral Invest 15 2011 983 991
36. T. Abe, M. Sakane, T. Ikoma, M. Kobayashi, S. Nakamura, and N. Ochiai Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats J Neurosurg Spine 9 2008 502 510
37. S.S. Banerjee, S. Tarafder, N.M. Davies, A. Bandyopadhyay, and S. Bose Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of beta-TCP ceramics Acta Biomater 6 2010 4167 4174
38. E. Boanini, M. Gazzano, and A. Bigi Ionic substitutions in calcium phosphates synthesized at low temperature Acta Biomater 6 2010 1882 1894
39. C. Mellier, F. Fayon, V. Schnitzler, P. Deniard, M. Allix, and S. Quillard Characterization and properties of novel gallium-doped calcium phosphate ceramics Inorg Chem 50 2011 8252 8260
40. S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M. Torres, and J.M. Ferreira Synthesis and structural characterization of strontium- and magnesium-co-substituted beta-tricalcium phosphate Acta Biomater 6 2010 571 576
41. J. Lu, J. Wei, Y. Yan, H. Li, J. Jia, and S. Wei Preparation and preliminary cytocompatibility of magnesium doped apatite cement with degradability for bone regeneration J Mater Sci Mater Med 22 2011 607 615
42. D. Guo, K. Xu, X. Zhao, and Y. Han Development of a strontium-containing hydroxyapatite bone cement Biomaterials 26 2005 4073 4083
43. G. Mestres, C. Le Van, and M.P. Ginebra Silicon-stabilized alpha-tricalcium phosphate and its use in a calcium phosphate cement: characterization and cell response Acta Biomater 8 2012 1169 1179
44. M. Bohner Silicon-substituted calcium phosphates - a critical view Biomaterials 30 2009 6403 6406
45. S. Kannan, S.I. Vieira, S.M. Olhero, P.M. Torres, S. Pina, and O.A. Da Cruz e Silva Synthesis, mechanical and biological characterization of ionic doped carbonated hydroxyapatite/beta-tricalcium phosphate mixtures Acta Biomater 7 2010 1835 1843
46. S. Pina, P.M. Torres, and J.M. Ferreira Injectability of brushite-forming Mg-substituted and Sr-substituted alpha-TCP bone cements J Mater Sci Mater Med 21 2010 431 438
47. H. Roussiere, G. Montavon, S. Laib, P. Janvier, B. Alonso, and F. Fayon Hybrid materials applied to biotechnologies: coating of calcium phosphates for the design of implants active against bone resorption J Mater Chem 15 2005 3869 3875
48. M. Bohner, J. Lemaitre, H.P. Merkle, and B. Gander Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid) J Pharm Sci 89 2000 1262 1270
49. S. Panzavolta, P. Torricelli, B. Bracci, M. Fini, and A. Bigi Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells J Inorg Biochem 103 2009 101 106
50. E.J. Blom, J. Klein-Nulend, J.G. Wolke, M.A. van Waas, F.C. Driessens, and E.H. Burger Transforming growth factor-beta1 incorporation in a calcium phosphate bone cement: material properties and release characteristics J Biomed Mater Res 59 2002 265 272
51. A. Ewald, D. Hosel, S. Patel, L.M. Grover, J.E. Barralet, and U. Gbureck Silver-doped calcium phosphate cements with antimicrobial activity Acta Biomater 7 2011 4064 4070
52. M. Takechi, Y. Miyamoto, K. Ishikawa, M. Nagayama, M. Kon, and K. Asaoka Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement J Biomed Mater Res 39 1998 308 316
53. A. Ratier, I.R. Gibson, S.M. Best, M. Freche, J.L. Lacout, and F. Rodriguez Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline Biomaterials 22 2001 897 901
54. M. Bohner, J. Lemaitre, P. VanLanduyt, P.Y. Zambelli, H.P. Merkle, and B. Gander Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system J Pharm Sci 86 1997 565 572
55. J. Lu, M. Descamps, J. Dejou, G. Koubi, P. Hardouin, and J. Lemaitre The biodegradation mechanism of calcium phosphate biomaterials in bone J Biomed Mater Res 63 2002 408 412
56. A. Gisep, R. Wieling, M. Bohner, S. Matter, E. Schneider, and B. Rahn Resorption patterns of calcium-phosphate cements in bone J Biomed Mater Res A 66 2003 532 540
57. C. Grossardt, A. Ewald, L.M. Grover, J.E. Barralet, and U. Gbureck Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells Tissue Eng Part A 16 2010 3687 3695
58. Z. Xia, L.M. Grover, Y. Huang, I.E. Adamopoulos, U. Gbureck, and J.T. Triffitt In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line Biomaterials 27 2006 4557 4565
59. F. Theiss, D. Apelt, B. Brand, A. Kutter, K. Zlinszky, and M. Bohner Biocompatibility and resorption of a brushite calcium phosphate cement Biomaterials 26 2005 4383 4394
60. K. Rzeszutek, F. Sarraf, and J.E. Davies Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth J Craniofac Surg 14 2003 301 307
61. A.R. Sheraly, D. Lickorish, F. Sarraf, and J.E. Davies Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo Curr Drug Deliv 6 2009 192 198
62. T. Steffen, T. Stoll, T. Arvinte, and R.K. Schenk Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery Eur Spine J 10 Suppl. 2 2001 S132 S140
63. L. Yang, S. Perez-Amodio, F.Y. Barrere-de Groot, V. Everts, C.A. van Blitterswijk, and P. Habibovic The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts Biomaterials 31 2010 2976 2989
64. N. Rochet, T. Balaguer, F. Boukhechba, J.P. Laugier, D. Quincey, and S. Goncalves Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement Biomaterials 30 2009 4260 4267
65. L. Sun, H.H. Xu, S. Takagi, and L.C. Chow Fast setting calcium phosphate cement-chitosan composite: mechanical properties and dissolution rates J Biomater Appl 21 2007 299 315
66. S. Oh, G. Lee, J. Park, and H. Kim Osteoclastic cell behaviors affected by the a-tricalcium phosphate based bone cements J Mater Sci 21 2010 3019 3027
67. Y. Yoshiko, G.A. Candeliere, N. Maeda, and J.E. Aubin Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization Mol Cell Biol 27 2007 4465 4474
68. S. Khoshniat, A. Bourgine, M. Julien, P. Weiss, J. Guicheux, and L. Beck The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals Cell Mol Life Sci 68 2011 205 218
69. M. Julien, D. Magne, M. Masson, M. Rolli-Derkinderen, O. Chassande, and C. Cario-Toumaniantz Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway Endocrinology 148 2007 530 537
70. S. Khoshniat, A. Bourgine, M. Julien, M. Petit, P. Pilet, and T. Rouillon Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium Bone 48 2011 894 902
71. P. Habibovic, D.C. Bassett, C.J. Doillon, C. Gerard, M.D. McKee, and J.E. Barralet Collagen biomineralization in vivo by sustained release of inorganic phosphate ions Adv Mater 22 2010 1858 1862
72. M. Otsuka, Y. Matsuda, Y. Suwa, J.L. Fox, and W.I. Higuchi A novel skeletal drug delivery system using a self-setting calcium phosphate cement. 5. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug J Pharm Sci 83 1994 1565 1568
73. M. Otsuka, Y. Nakahigashi, Y. Matsuda, J.L. Fox, W.I. Higuchi, and Y. Sugiyama Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement J Control Release 52 1998 281 289
74. M. Otsuka, Y. Matsuda, A.A. Baig, A. Chhettry, and W.I. Higuchi Calcium-level responsive controlled drug delivery from implant dosage forms to treat osteoporosis in an animal model Adv Drug Deliv Rev 42 2000 249 258
75. T. Higuchi Rate of release of medicaments from ointment bases containing drugs in suspension J Pharm Sci 50 1961 874 875
76. T. Higuchi Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices J Pharm Sci 12 1963 1145 1149
77. M. Otsuka, H. Nakagawa, A. Ito, and W.I. Higuchi Effect of geometrical structure on drug release rate of a three-dimensionally perforated porous apatite/collagen composite cement J Pharm Sci 99 2010 286 292
78. H. Gautier, V. Chamblain, P. Weiss, C. Merle, and J.M. Bouler In vitro characterisation of calcium phosphate biomaterials loaded with lidocaine hydrochloride and morphine hydrochloride J Mater Sci Mater Med 21 2010 3141 3150
79. H. Gautier, A. Plumecocq, G. Amador, P. Weiss, C. Merle, and J.M. Bouler In vitro characterization of calcium phosphate biomaterial loaded with linezolid for osseous bone defect implantation J Biomater Appl 26 2010 811 828
80. M. Brouillet, H. Gautier, A.F. Miegeville, J.M. Bouler, C. Merle, and J. Caillon Inactivation of Staphylococcus aureus in calcium phosphate biomaterials via isostatic compression J Biomed Mater Res B: Appl Biomater 91 2009 348 353
81. F. Tamimi, J. Torres, R. Bettini, F. Ruggera, C. Rueda, and M. Lopez-Ponce Doxycycline sustained release from brushite cements for the treatment of periodontal diseases J Biomed Mater Res A 85 2008 707 714
82. H.P. Stallmann, C. Faber, A.L. Bronckers, A.V. Nieuw Amerongen, and P.I. Wuisman In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile BMC Musculoskelet Disord 7 2006 18
83. T. Boontheekul, and D.J. Mooney Protein-based signaling systems in tissue engineering Curr Opin Biotechnol 14 2003 559 565
84. M.M. Deckers, R.L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van Der Bent, and S.E. Papapoulos Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A Endocrinology 143 2002 1545 1553
85. S.J. Polak, S.K. Levengood, M.B. Wheeler, A.J. Maki, S.G. Clark, and A.J. Johnson Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds Acta Biomater 7 2011 1760 1771
86. P.Q. Ruhe, H.C. Kroese-Deutman, J.G. Wolke, P.H. Spauwen, and J.A. Jansen Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits Biomaterials 25 2004 2123 2132
87. A.J. Haddad, S.A. Peel, C.M. Clokie, and G.K. Sandor Closure of rabbit calvarial critical-sized defects using protective composite allogeneic and alloplastic bone substitutes J Craniofac Surg 17 2006 926 934
88. H.J. Seeherman, M. Bouxsein, H. Kim, R. Li, X.J. Li, and M. Aiolova Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model J Bone Joint Surg Am 86-A 2004 1961 1972
89. H.J. Seeherman, K. Azari, S. Bidic, L. Rogers, X.J. Li, and J.O. Hollinger RhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii J Bone Joint Surg Am 88 2006 1553 1565
90. J.R. Dimar, S.D. Glassman, K.J. Burkus, and L.Y. Carreon Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft Spine 31 2006 2534 2539 discussion 2540
91. S.D. Boden, J. Kang, H. Sandhu, and J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine (Phila Pa 1976) 27 2002 2662 2673
92. H. Peng, A. Usas, A. Olshanski, A.M. Ho, B. Gearhart, and G.M. Cooper VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis J Bone Miner Res 20 2005 2017 2027
93. I. Vajanto, T.T. Rissanen, J. Rutanen, M.O. Hiltunen, T.T. Tuomisto, and K. Arve Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ J Gene Med 4 2002 371 380
94. D.H. Kempen, L. Lu, A. Heijink, T.E. Hefferan, L.B. Creemers, and A. Maran Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration Biomaterials 30 2009 2816 2825
95. Z.S. Patel, H. Ueda, M. Yamamoto, Y. Tabata, and A.G. Mikos In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds Pharm Res 25 2008 2370 2378
96. M. Ramazanoglu, R. Lutz, C. Ergun, C. von Wilmowsky, E. Nkenke, and K.A. Schlegel The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration Clin Oral Implants Res 22 2011 1433 1439
97. D.R. Sumner, T.M. Turner, R.M. Urban, R.M. Leven, M. Hawkins, and E.H. Nichols Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury J Orthop Res 19 2001 85 94
98. E.J. Blom, J. Klein-Nulend, L. Yin, M.A. van Waas, and E.H. Burger Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects Clin Oral Implants Res 12 2001 609 616
99. V. Luginbuehl, E. Wenk, A. Koch, B. Gander, H.P. Merkle, and L. Meinel Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration Pharm Res 22 2005 940 950
100. E. Damien, K. Hing, S. Saeed, and P.A. Revell A preliminary study on the enhancement of the osteointegration of a novel synthetic hydroxyapatite scaffold in vivo J Biomed Mater Res A 66 2003 241 246
101. J. Guicheux, D. Heymann, A.V. Rousselle, F. Gouin, P. Pilet, and S. Yamada Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study Bone 22 1998 25 31
102. J. Guicheux, O. Gauthier, E. Aguado, P. Pilet, S. Couillaud, and D. Jegou Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study J Bone Miner Res 13 1998 739 748
103. K. Saleh, M. Olson, S. Resig, B. Bershadsky, M. Kuskowski, and T. Gioe Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program J Orthop Res 20 2002 506 515
104. S. Aslam, and R.O. Darouiche Antimicrobial therapy for bone and joint infections Curr Infect Dis Rep 11 2009 7 13
105. C. Wang, T. Huang, J. Wang, and H. Chen The often poor clinical outcome of infected total knee arthroplasty J Arthroplasty 17 2002 608 614
106. D.J. Moojen, S.N. Spijkers, C.S. Schot, M.W. Nijhof, H.C. Vogely, and A. Fleer Identification of orthopaedic infections using broad-range polymerase chain reaction and reverse line blot hybridization J Bone Joint Surg Am 89 2007 1298 1305
107. J.G. Hendriks, J.R. van Horn, H.C. van der Mei, and H.J. Busscher Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection Biomaterials 25 2004 545 556
108. C. Hamanishi, K. Kitamoto, S. Tanaka, M. Otsuka, Y. Doi, and T. Kitahashi A self-setting TTCP-DCPD apatite cement for release of vancomycin J Biomed Mater Res 33 1996 139 143
109. A.M. Jacobs, A.M. Seifert, T.J. Kirisits, and H.R. Protzel Use of antibiotic-loaded bone cement in the management of common infections of the foot and ankle Clin Podiatr Med Surg 7 1990 523 544
110. J.R. Youngman, G.L. Ridgway, and F.S. Haddad Antibiotic-loaded cement in revision joint replacement Hosp Med 64 2003 613 616
111. M. Diefenbeck, T. Muckley, and G.O. Hofmann Prophylaxis and treatment of implant-related infections by local application of antibiotics Injury 37 Suppl. 2 2006 S95 S104
112. H.P. Stallmann, C. Faber, A.L. Bronckers, A.V. Nieuw Amerongen, and P.I. Wuisman Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement J Antimicrob Chemother 54 2004 472 476
113. J. Schnieders, U. Gbureck, R. Thull, and T. Kissel Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement Biomaterials 27 2006 4239 4249
114. P.J. Jiang, S. Patel, U. Gbureck, R. Caley, and L.M. Grover Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride J Biomed Mater Res B: Appl Biomater 93 2010 51 58
115. U. Joosten, A. Joist, T. Frebel, B. Brandt, S. Diederichs, and C. von Eiff Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo Biomaterials 25 2004 4287 4295
116. K. Urabe, K. Naruse, H. Hattori, M. Hirano, K. Uchida, and K. Onuma In vitro comparison of elution characteristics of vancomycin from calcium phosphate cement and polymethylmethacrylate J Orthop Sci 14 2009 784 793
117. D. Neut, J.G. Hendriks, J.R. van Horn, H.C. van der Mei, and H.J. Busscher Pseudomonas aeruginosa biofilm formation and slime excretion on antibiotic-loaded bone cement Acta Orthop 76 2005 109 114
118. M. Kazemzadeh-Narbat, J. Kindrachuk, K. Duan, H. Jenssen, R.E. Hancock, and R. Wang Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections Biomaterials 31 2010 9519 9526
119. D.J. Moojen, H.C. Vogely, A. Fleer, P.G. Nikkels, P.A. Higham, and A.J. Verbout Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants - an experimental study in the rabbit J Orthop Res 27 2009 710 716
120. A. Sudo, M. Hasegawa, A. Fukuda, and A. Uchida Treatment of infected hip arthroplasty with antibiotic-impregnated calcium hydroxyapatite J Arthroplasty 23 2008 145 150
121. J. Parvizi, K.J. Saleh, P.S. Ragland, A.E. Pour, and M.A. Mont Efficacy of antibiotic-impregnated cement in total hip replacement Acta Orthop 79 2008 335 341
122. H. Van de Belt, D. Neut, W. Schenk, J.R. van Horn, H.C. van Der Mei, and H.J. Busscher Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements Biomaterials 22 2001 1607 1611
123. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: a common cause of persistent infections Science 284 1999 1318 1322
124. D. Neut, H. van de Belt, I. Stokroos, J.R. van Horn, H.C. van der Mei, and H.J. Busscher Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery J Antimicrob Chemother 47 2001 885 891
125. D. Ip, S. Yam, and C. Chen Implications of the changing pattern of bacterial infections following total joint replacements J Orthop Surg 13 2005 125 130
126. T.N. Joseph, A.L. Chen, and P.E. Di Cesare Use of antibiotic-impregnated cement in total joint arthroplasty J Am Acad Orthop Surg 11 2003 38 47
127. H.G. Bone, D. Hosking, J.P. Devogelaer, J.R. Tucci, R.D. Emkey, and R.P. Tonino Ten years' experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 350 2004 1189 1199
128. S.V. Dorozhkin, and M. Epple Biological and medical significance of calcium phosphates Angew Chem Int Ed Engl 41 2002 3130 3146
129. E. Boanini, P. Torricelli, M. Gazzano, R. Giardino, and A. Bigi Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells Biomaterials 29 2008 790 796
130. X. Shi, Y. Wang, L. Ren, Y. Gong, and D.A. Wang Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications Pharm Res 26 2009
131. C. Faucheux, E. Verron, A. Soueidan, S. Josse, M.D. Arshad, and P. Janvier Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro J Biomed Mater Res A 2008 46 56
132. H. Roussire, F. Fayon, B. Alonso, T. Rouillon, V. Schnitzler, and E. Verron Reaction of zoledronate with b-tricalcium phosphate for the design of potential drug device Comb Syst Chem Mater 2008 182 191
133. B. Peter, O. Gauthier, S. Laib, B. Bujoli, J. Guicheux, and P. Janvier Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats J Biomed Mater Res A 76 2006 133 143
134. E. Verron, O. Gauthier, P. Janvier, P. Pilet, J. Lesoeur, and B. Bujoli In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite Biomaterials 31 2010 7776 7784
135. Yamaguchi M, Neale Weitzmann M. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-kappaB activation. Mol Cell Biochem 2011.
136. E. Bonnelye, A. Chabadel, F. Saltel, and P. Jurdic Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro Bone 42 2008 129 138
137. S.J. Saint-Jean, C.L. Camire, P. Nevsten, S. Hansen, and M.P. Ginebra Study of the reactivity and in vitro bioactivity of Sr-substituted alpha-TCP cements J Mater Sci Mater Med 16 2005 993 1001
138. S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, and J.M. Ferreira Newly developed Sr-substituted alpha-TCP bone cements Acta Biomater 6 2010 928 935
139. S. Panzavolta, P. Torricelli, L. Sturba, B. Bracci, R. Giardino, and A. Bigi Setting properties and in vitro bioactivity of strontium-enriched gelatin-calcium phosphate bone cements J Biomed Mater Res A 84 2008 965 972
140. M. Tian, F. Chen, W. Song, Y. Song, Y. Chen, and C. Wan In vivo study of porous strontium-doped calcium polyphosphate scaffolds for bone substitute applications J Mater Sci Mater Med 20 2009 1505 1512
141. E. Verron, M. Masson, S. Khoshniat, L. Duplomb, Y. Wittrant, and M. Baud'huin Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts Br J Pharmacol 159 2010 1681 1692
142. E. Verron, A. Loubat, G.F. Carle, C. Vignes-Colombeix, I. Strazic, and J. Guicheux Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes Biochem Pharmacol 2011 10.1016/j.bcp.2011.12.015
143. M. Korbas, E. Rokita, W. Meyer-Klaucke, and J. Ryczek Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite J Biol Inorg Chem 9 2004 67 76
144. N. Federman, N. Bernthal, F.C. Eilber, and W.D. Tap The multidisciplinary management of osteosarcoma Curr Treat Options Oncol 2009
145. S. Miura, Y. Mii, Y. Miyauchi, H. Ohgushi, T. Morishita, and K. Hohnoki Efficacy of slow-releasing anticancer drug delivery systems on transplantable osteosarcomas in rats Jpn J Clin Oncol 25 1995 61 71
146. T. Tani, K. Okada, S. Takahashi, N. Suzuki, Y. Shimada, and E. Itoi Doxorubicin-loaded calcium phosphate cement in the management of bone and soft tissue tumors In Vivo 20 2006 55 60
147. Y. Tanzawa, H. Tsuchiya, T. Shirai, H. Nishida, K. Hayashi, and A. Takeuchi Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma J Orthop Sci 16 2011 77 84
148. F. Chung, E. Ritchie, and J. Su Postoperative pain in ambulatory surgery Anesth Analg 85 1997 808 816
149. R. Pollock, I. Alcelik, C. Bhatia, G. Chuter, K. Lingutla, and C. Budithi Donor site morbidity following iliac crest bone harvesting for cervical fusion: a comparison between minimally invasive and open techniques Eur Spine J 17 2008 845 852
150. J. Silber, D. Anderson, S. Daffner, B. Brislin, J. Leland, and A. Hilibrand Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion Spine 28 2003 134 139
151. D. Mach, S. Rogers, M. Sabino, N. Luger, M. Schwei, and J. Pomonis Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur Neuroscience 113 2002 155 166
152. R. Zaslansky, E. Eisenberg, B. Peskin, E. Sprecher, D. Reis, and C. Zinman Early administration of oral morphine to orthopedic patients after surgery J Opioid Manag 2 2006 88 92
153. S. Rasche, and T. Koch Regional anaesthesia versus general anaesthesia - pathophysiology and clinical implications Anaesthesiol Reanim 29 2004 30 38
154. M. Otsuka, Y. Matsuda, Y. Suwa, J.L. Fox, and W.I. Higuchi A novel skeletal drug delivery system using self-setting calcium phosphate cement. 2. Physicochemical properties and drug release rate of the cement-containing indomethacin J Pharm Sci 83 1994 611 615
155. M. Otsuka, Y. Nakahigashi, Y. Matsuda, J.L. Fox, and W.I. Higuchi A novel skeletal drug delivery system using self-setting calcium phosphate cement. 7. Effect of biological factors on indomethacin release from the cement loaded on bovine bone J Pharm Sci 83 1994 1569 1573
156. M. Otsuka, Y. Nakahigashi, Y. Matsuda, T. Kokubo, S. Yoshihara, and H. Fujita The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement Biomed Mater Eng 7 1997 291 302
157. M. Otsuka, Y. Matsuda, Y. Suwa, J.L. Fox, and W.I. Higuchi A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement J Pharm Sci 83 1994 259 263